Skin prick test with self-saliva in patients with oral aphthoses: A new diagnostic pathergy for behcet's disease and recurrent aphthosis

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 3, 2011, Pages 164-170

  Togashi, Ari ^a   Saito, Sanae ^a   Kaneko, Fumio ^a   Nakamura, Koichiro ^b   Oyama, Noritaka ^c  

^a Southern Tohoku General Hospital   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aphthous ulceration; Behcet's disease; Pathergy reaction; Prick test; Recurrent oral aphthosis; Saliva

Indexed keywords

CD68 ANTIGEN;

ADULT; APHTHOUS STOMATITIS; APHTHOUS ULCER; ARTICLE; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM DETECTION; BEHCET DISEASE; CD4+ T LYMPHOCYTE; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ERYTHEMA; FEMALE; FOREARM; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MONOCYTE; MOUTH FLORA; PRICK TEST; RECURRENT DISEASE; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SKIN DEFECT; SKIN MANIFESTATION; SKIN PRICK TEST; SKIN TEST; STREPTOCOCCUS MITIS; STREPTOCOCCUS SANGUINIS;

EID: 79958185441     PISSN: 18715281     EISSN: 18715281     Source Type: Journal    
DOI: 10.2174/187152811795564109     Document Type: Article

References (47)

1. Behcet, H. Uber rezidivierende, aphthous durch ein Virus verursachte Geschwuere am Mund, am Auge und an den Genitalien. Dermatol. Wochenschri., 1937, 105, 1152-1157.
2. Adamantiades, B. Sur un cas d'iritis a hypopion recidivant. Ann. Ocul. (Paris), 1931, 168, 271-278.
3. Altenburg, A.; Papoutsis, N.; Orawa, H.; Martus, P.; Krause, I.; Zouboulis, C.C. Epidemiology and clinical manifestations of Adamantiades-Behcet's disease in Germany-Current pathogenic concepts and therapeutic possibilities. J. Dtsch. Dermatol. Ges., 2006, 4, 49-64.
4. Alpsoy, E.; Zouboulis, C.C.; Ehrlich, G.E. Mucocutaneous lesions of Behcet's disease. Yonsei. Med, J., 2007, 48, 573-585.
5. Ohno, S.; Ohguchi, M.; Hirose, S.; Matsuda, H.; Wakisaka, A.; Aizawa, M. Close association of HLA-Bw51 with Behcet's disease. Arch. Ophthalmol., 1982, 100, 1455-1458.
6. Zouboulis, C.C.; May, T. Pathogenesis of Adamantiades-Behcet's disease. Med. Microbiol. Immunol., 2003, 192, 149-155.
7. Karaycian, A.; Zouboulis, C.C. An update on Behcet's disease. J. Eur. Acad. Dermat-Venereol., 2007, 21, 1-10.
8. Krause, I.; Weinberger, A. Behcet's disease. Curr. Opin. Rheum., 2008, 20, 82-87.
9. Kaneko, F.; Kaneda, T.; Ohnishi, O.; Kishiyama, K.; Takashima, K.; Fukuda, H.; Kado, Y. Infection allergy in Behcet's disease (1). Jpn. J. Allergol., 1978, 27, 440-450.
10. Kaneko, F.; Oyama, N.; Nishibu, A. Streptococcal infection in the pathogenesis of Behcet's disese and clinical effects of minocycline on the disease symptoms. Yonsei. Med. J., 1997, 38, 444-454.
11. Mumcu, G.; Inanc, N.; Ergan, T.; Ikiz, K.; Gunes, M.; Islek, U.; Yavus, S.; Sur, H.; Atalay, T.; Direskeneli, H. Oral health is impaired in Behcet's disease and is associated with disease activity. Rheumatology (Oxford), 2004, 43, 1028-1033.
12. Yokota, K.; Hayashi, S.; Araki, Y.; Isogai, E.; Kotake, S.; Yoshikawa, K.; Fujii, N.; Hirai, Y.; Oguma, K. Characterization of Streptococcus sanguis isolated from patients with Behcet's disease. Microbiol. Immunol., 1995, 39, 729-732.
13. Isogai, E.; Ohno, S.; Takashi, K.; Yoshikawa, K.; Turumizu, T.; Isogai, H.; Yokota, Y.; Hashimoto, T.; Shimizu, H.; Matsuda, H.; Fujii, N.; Yamaguchi, M.; Oguma, K. Close association of Streptococcus sanguis uncommon serotypes with Behcet's disease. Bifidobacteria. Microflora., 1990, 9, 27-41.
14. Isogai, E.; Ohno, S.; Kotake, S.; Isogai, H.; Tsurumizu, T.; Fujii, N.; Syuto, B.; Yamaguchi, M.; Matsuda, H.; Oguma, K. Chemiluminescence of neutrophils from patients with Behcet's disease and its correlation with an increased proportion of uncommon selotypes of Streptococcus sanguis in the oral flora. Arch. Oral. Biol., 1990, 35, 43-48.
15. Kaneko, F.; Takahashi, Y.; Muramatsu, Y.; Miura, Y. Immunological studies on aphthous ulcer and erythema nodosumlike eruptions in Behcet's disease. Br. J. Dermatol., 1985, 113, 303-312.
16. The Behcet's Disease Research Committee of Japan. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease -A multicenter study. J. Rheumatol. 1989, 16, 506-511.
17. Graykowski, E.A.; Baril, M.F.; Boyd, L.M.; Stanley, H.R. Recurrent aphthous stomatitis, Clinical therapeutic and histopathologic and hypersensitivity aspects. JAMA, 1966, 196, 637-644.
18. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet, 1990, 335, 1078-1080.
19. Sakane, T.; Takeno, M.; Suzuki, N.; Inaba, G. Current concepts: Behcet's disease. N. Eng. J. Med., 1999, 341, 1284-1291.
20. Suzuki-Krokawa, M.; Suzuki, N. Behcet's disease. Clin. Exp. Med., 2004, 3, 10-20.
21. Emilson, C.G.; Bratthal, D. Growth of Streptococcus mutans on various selective media. J. Clin. Microbiol. 1976, 4, 95-98.
22. Kaneko, F.; Saito, S.; Togashi, A.; Oyama, N.; Nakamura, K. Prick test with self-saliva as an auxiliary diagnostic measure in Behcet's disease. Jpn. J. Dermatol., 2010, 120, 1901-1905. (in Japanese)
23. Haim, S.; Sobel, J.D.; Friedman-Birnbaum, R.; Lichtig, C. Histological and direct immunofluorescence study of cutaneous hyperreactivity in Behcet's disease. Br. J. Dermatol., 1976, 95, 631-636.
24. Tuzun, Y.; Yazici, H.; Pazarli, H.; Yalcin, B.; Yurdakul, S.; Muftuoglu, A. The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behcet's disease in Turkey. Acta. Dermato-Venereol. (Stockholm), 1978, 59, 77-79.
25. Davies, P.G.; Fordham, J.N.; Kirwan, J.R.; Barnes, C.G.; Dinning, W.J. The pathergy test and Behcet's syndrome in Britain. Ann. Rheum. Dis., 1984; 43, 70-73.
26. Jorizzo, J.L.; Solomon, A.R. Behcet's disease. Immunopathologic and histologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch. Pathol. Lab. Med., 1985, 109, 747-741.
27. Friedman-Birnbaun, R.; Bergman, R.; Aizen, E. Sensitivity and specificity of pathergy test results in Israeli patients with Behcet's disease. Cutis, 1990, 45, 261-264.
28. Fresko, I.; Yazici, H.; Bayramicli, M.; Yurdakul, S.; Mat, C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behcet's syndrome. Ann. Rheum. Dis., 1933, 52, 619-620.
29. Inaloz, H.S.; Everekliosgluu, C.; Unal, B.; Kirtak, N.; Eralp, A.; Inaloz, S.S. The significans of immunohistochemistry in the skin pathergy reaction of patients with Behcet's syndrome. J. Eur. Acad. Dermatol. Venereol., 2004, 18, 56-61.
30. Davachi, F.; Chans-Davachi, C.; Shahram, F.; Nadji, A.; Shams, H.; Ghodsi, Z.; Akhlaghi, M.; Naderi, N.; Sadeghi-Abdolahi, B. Pathergy test in Behcet's disease in incidence over the time. APKAR. J. Rheumatol., 2007, 10, 333-335.
31. The Report of the Research Committee of Behcet's Disease. Japanese Ministry of Health, Labour and Welfare. Ishigatsubo, Y., 2010 (in Japanese).
32. Jorrizzo, J.L.; Abernothy, J.L.; White, W.L.; Mongelsdorf, H.C.; Zouboulis, C.C.; Sarica, R.; Gaffney, K.; Mat, C.; Yazici, H.; Al Lalaan, A.; Assad-Kahalil, S.H.; Kaneko, F.; Jorizzo, E.A.F. Mucocutaneous criteria for the diagnosis of Behcet's disease: an analysis of clinicopathologic data from multiple international centers. J. Am. Acard. Dermatol., 1995, 32, 968-976.
33. Lew, W.; Chang, J.Y.; Jung, T.Y.; Bang, D. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesion of Behcet's disease. Br. J. Dermatol., 2008, 158, 505-511.
34. Yanagihori, H.; Oyama, N.; Nakamura, K.; Mizuki, N.; Oguma, K.; Kaneko, F. Role of IL-12B promoter polymorphisum in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immmunoreactivity against Streptococcus sanguinis antigen. J. Invest. Dermatol., 2006, 126, 1534-1540.
35. Kaneko, F.; Togashi, A.; Saito, S.; Sakuma, H.; Oyama, N.; Nakamura, K.; Yokota, K.; Oguma, K. The role of the IL-12 cytokine family in oral disease: Behcet's disease (Adamantiades- Behcet's disease). Clin. Dev. Immunol., 2011, 2011, 681956.
36. Isogai, E.; Isogai, H.; Kotake, S.; Ohno, S.; Ishihara, M.; Aeki, K.; Tojo, M.; Kaneko, F.; Yokota, K.; Oguma, K. Antibody cross reactivity from sera of patients with Behcet's disease with synthetic peptides that have homologies with protein from Streptococcus sanguis. J. Appl. Res., 2002, 2, 1-7.
37. Yoshikawa, K.; Kotake, S.; Kubota, T.; Kimura, K.; Isogai, E.; Fujii, N. Cloning and sequencing of BES-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from patients with Behcet's disease. Zentbl. Bakteriol., 1998, 287, 449-460.
38. Isogai, E.; Isogai, H.; Kotake, S.; Ohno, S.; Ikimura, K.; Oguma, K. Role of Streptococcus sanguis and traumatic factors in Behcet's disease. J. Appl. Res., 2003, 3, 64-75.
39. Tojo, M.; Yanagihori, H.; Zheng, X.; Oyama, N.; Isogai, E.; Kimura, K.; Nakamura, K.; Kaneko, F. Bes-1 DNA fragment encoding Streptococcal antigen in skin lesions from patients with Behcet's disease. J. Appl. Res., 2003, 3, 232-238.
40. Kaneko, F.; Takahashi, Y.; Muramatsu, R.; Minagawa, T. Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease. Br. J. Dermatol., 1985, 113, 313-318.
41. Hirohata, S.; Oka, H.; Mizushima, Y. Streptococcal antigens stimulate production of IL-6 and interferon-γ by cells from patients with Behcet's disease. Cell. Immunol., 1992, 140, 410-419.
42. Zarember, K.A.; Godowski, P.J. Tissue expression of human Tolllike receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol., 2002, 168, 554-561.
43. Hornung, V.; Rothenfusser, S.; Britsch, S.; Krug, A.; Jahrsdörfer, B.; Giese, T.; Endres, S.; Hartmann, G. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol., 2002, 168, 4531-4537.
44. Durranni, O.; Wallace, G.R.; Hamburger, J.; Hamburger, J. Tolllike receptors (TLRs) expression in oral ulcer biopsies from Behcet's disease (BD) patients, a role for the innate immune syste in BD. Clin. Exp. Rheumatol., 2004, 22(Suppl. 34), S1-S93.
45. Yavus, S.; Elbir, Y.; Tulunay, A.; Ekisioglu-Demirap, E.; Direskeneli, H. Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet's disease etiopathogenesis. Rheumatol. Int., 2008, 28, 401-406.
46. Mumcu, G.; Inac, N.; Yavuz, S.; Direskeneli, H. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet's disease. Clin. Exp. Rheumatol., 2007, 25, S27-S33.
47. Stanford, M.; Whittal, T.; Bergemeier, L.A.; Lindhald, M.; Lundin, S.; Shinneck, T.; Mizushima, Y.; Halmgren, J.; Lehner, T. Oral toleration with peptides 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin. Exp. Immunol., 2004, 137, 201-208.